Efficacy of cisplatin combined with topotecan in patients with advanced or recurrent ovarian cancer as second- or higher-line palliative chemotherapy

The aim of this study was to evaluate the outcomes of patients with advanced or recurrent ovarian cancer treated with cisplatin combined with topotecan as second- or higher-line palliative chemotherapy. We retrospectively reviewed the medical records of patients with advanced or recurrent ovarian ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Myung-Won, Ryu, Hyewon, Song, Ik-Chan, Yun, Hwan-Jung, Jo, Deog-Yeon, Ko, Young Bok, Lee, Hyo-Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440193/
https://www.ncbi.nlm.nih.gov/pubmed/32332673
http://dx.doi.org/10.1097/MD.0000000000019931

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440193/
https://www.ncbi.nlm.nih.gov/pubmed/32332673
http://dx.doi.org/10.1097/MD.0000000000019931

Ejemplares similares